Sarah Vlach, MD
Physical Medicine & Rehabilitation · Idaho Falls, IDNPI 1326002221
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Nevro Corp. at 46.2% of the total. Reporting peaked in 2020 at $193 and has fallen 86.8% since, to $25 in 2025.
Across 24 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$235
- AbbVie$101
- Teva Pharmaceuticals USA, Inc.$62
- Ipsen Biopharmaceuticals, Inc$48
- Amgen$26
- Stimwave Technologies Incorporated$23
- plus $15 from 1 others
What the payments were for
- Food & beverage$510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 8 | $235 |
| AbbVie(2 entities) | 7 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Amgen | 1 | $26 |
| Stimwave Technologies Incorporated | 1 | $23 |
| Nalu Medical, Inc. | 1 | $15 |
How this compares
$510 in reported general payments places this provider in the 55th percentile of 38 physical medicine & rehabilitation providers in Idaho.
See all physical medicine & rehabilitation providers in Idaho →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 80 | $770 |
| Tramadol Hcl | 18 | $62 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Idaho Falls
- Andrew CooperIdaho Falls$3K
- Troy BushmanIdaho Falls$1K
- Bryan BakerIdaho Falls$1K
- Tyler HedinIdaho Falls$464
- David SimonIdaho Falls$74
- Neilly BuckalewCoeur D Alene$33K
- Robert FriedmanBoise$18K
- Donald AdamsMeridian$6K
- James WhitakerBoise$4K
- Christian GussnerMeridian$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.